# A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites

> **NCT02530398** · PHASE1 · UNKNOWN · sponsor: **Dongfang Hospital Beijing University of Chinese Medicine** · enrollment: 48 (estimated)

## Conditions studied

- Digestive System Cancer
- Malignant Ascites

## Interventions

- **DRUG:** Cinobufacini Injection

## Key facts

- **NCT ID:** NCT02530398
- **Lead sponsor:** Dongfang Hospital Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530398, "A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02530398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*